Triple

T15313580
Position Surface form Disambiguated ID Type / Status
Subject CRISPR-Cas9 gene-editing technology E366097 entity
Predicate hasVariant P455 FINISHED
Object SaCas9
SaCas9 is a compact Cas9 nuclease derived from Staphylococcus aureus that enables CRISPR-based genome editing, particularly useful where smaller delivery vectors such as AAV are required.
E1150943 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: SaCas9 | Statement: [CRISPR-Cas9 gene-editing technology, hasVariant, SaCas9]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: SaCas9
Context triple: [CRISPR-Cas9 gene-editing technology, hasVariant, SaCas9]
  • A. Cpf1 (Cas12a)
    Cpf1 (Cas12a) is a CRISPR-associated endonuclease used for genome editing that recognizes different DNA target sequences and creates staggered cuts, offering distinct advantages and applications compared to Cas9.
  • B. CASP13
    CASP13 is the 13th Critical Assessment of protein Structure Prediction experiment, an international community-wide competition that benchmarks computational methods for predicting 3D protein structures.
  • C. CRISPR-Cas9 gene-editing technology
    CRISPR-Cas9 gene-editing technology is a revolutionary molecular tool that allows scientists to precisely modify DNA within living organisms, transforming research, medicine, and biotechnology.
  • D. CASP14
    CASP14 is the fourteenth edition of the Critical Assessment of protein Structure Prediction experiment, a community-wide benchmark for evaluating computational methods in protein structure modeling.
  • E. CESAER
    CESAER is a European association of leading universities of science and technology that collaborates to advance engineering education, research, and innovation.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: SaCas9
Triple: [CRISPR-Cas9 gene-editing technology, hasVariant, SaCas9]
Generated description
SaCas9 is a compact Cas9 nuclease derived from Staphylococcus aureus that enables CRISPR-based genome editing, particularly useful where smaller delivery vectors such as AAV are required.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: SaCas9
Target entity description: SaCas9 is a compact Cas9 nuclease derived from Staphylococcus aureus that enables CRISPR-based genome editing, particularly useful where smaller delivery vectors such as AAV are required.
  • A. Cpf1 (Cas12a)
    Cpf1 (Cas12a) is a CRISPR-associated endonuclease used for genome editing that recognizes different DNA target sequences and creates staggered cuts, offering distinct advantages and applications compared to Cas9.
  • B. CASP13
    CASP13 is the 13th Critical Assessment of protein Structure Prediction experiment, an international community-wide competition that benchmarks computational methods for predicting 3D protein structures.
  • C. CRISPR-Cas9 gene-editing technology
    CRISPR-Cas9 gene-editing technology is a revolutionary molecular tool that allows scientists to precisely modify DNA within living organisms, transforming research, medicine, and biotechnology.
  • D. CASP14
    CASP14 is the fourteenth edition of the Critical Assessment of protein Structure Prediction experiment, a community-wide benchmark for evaluating computational methods in protein structure modeling.
  • E. CESAER
    CESAER is a European association of leading universities of science and technology that collaborates to advance engineering education, research, and innovation.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d85a113ee881908e297a1d38dd79fa completed April 10, 2026, 2:01 a.m.
NER Named-entity recognition batch_69e03dd050108190a584543cb93943a4 completed April 16, 2026, 1:39 a.m.
NED1 Entity disambiguation (via context triple) batch_69ff01e70a308190a7d6b91178c39bd3 completed May 9, 2026, 9:44 a.m.
NEDg Description generation batch_69ff02745d1c819099f6261eced78dd0 completed May 9, 2026, 9:46 a.m.
NED2 Entity disambiguation (via description) batch_69ff031d58048190852dae8a18981d35 completed May 9, 2026, 9:49 a.m.
Created at: April 10, 2026, 3:16 a.m.